Medlab Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.90 M
as on 15-11-2024
- Satisfied Charges ₹ 7.00 M
as on 15-11-2024
- Revenue 6.37%
(FY 2023)
- Profit -83.36%
(FY 2023)
- Ebitda -160.76%
(FY 2023)
- Net Worth 0.26%
(FY 2023)
- Total Assets 5.24%
(FY 2023)
About Medlab Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.90 M. The company has closed loans amounting to ₹7.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rishi Desai, Pranay Desai, and Hemant Desai serve as directors at the Company.
- CIN/LLPIN
U85195GJ2005PTC103225
- Company No.
103225
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medlab Research Private Limited offer?
Medlab Research Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Chemical Intermediates, Chemical Reagents & Catalysts, Potassium Salts, Inorganic Salts, Flavours & Aromatics, Food Preservative, Zinc salts, Acrylic Polymers, Heptahydrate.
Who are the key members and board of directors at Medlab Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranay Desai  | Director | 18-May-2017 | Current |
| Rishi Desai | Director | 18-May-2017 | Current |
| Hemant Desai | Director | 16-Aug-2007 | Current |
Financial Performance of Medlab Research.
Medlab Research Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.37% increase. The company also saw a substantial fall in profitability, with a 83.36% decrease in profit. The company's net worth moved up by a moderate rise of 0.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medlab Research?
In 2023, Medlab Research had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 May 2020 | ₹2.40 M | Open |
Dena Bank Creation Date: 01 Mar 2012 | ₹7.50 M | Open |
Dena Bank Creation Date: 29 Apr 2014 | ₹4.00 M | Satisfied |
How Many Employees Work at Medlab Research?
Unlock and access historical data on people associated with Medlab Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medlab Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medlab Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
